ALPIVAB
LIVE

Serial Number

79202696

Owner

Seqirus UK Limited

Filing Date

Nov 30, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ALPIVAB Trademark

Serial Number: 79202696 • Registration: 5238911

ALPIVAB is a trademark filed by Seqirus UK Limited on November 30, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Seqirus UK Limited (138 trademarks)

Point, 29 Market Street

Entity Type: 98

BioCryst Pharmaceuticals, Inc. (40 trademarks)

2190 Parkway Lake Drive
Birmingham, AL 35244

Entity Type: 03

Trademark Details

Filing Date

November 30, 2016

Registration Date

July 11, 2017

Published for Opposition

April 25, 2017

Cancellation Date

January 26, 2024

Goods & Services

Pharmaceutical antiviral preparations; vaccines

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Oct 26, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 3, 2024 INTS
INVALIDATION PROCESSED
Oct 3, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 27, 2024 INTR
CANCELLED SECTION 71
Jan 26, 2024 C71T
CHANGE OF OWNER RECEIVED FROM IB
Dec 11, 2021 CHLD
NOTIFICATION PROCESSED BY IB
Sep 1, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 11, 2017 FICS
FINAL DISPOSITION PROCESSED
Aug 11, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 10, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2017 R.PR
PUBLISHED FOR OPPOSITION
Apr 25, 2017 PUBO
NOTICE OF PUBLICATION
Apr 5, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Mar 14, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2017 CNSA
ASSIGNED TO EXAMINER
Mar 10, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2017 REPR